UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Phase II study of treatment of advanced ovarian cancer with folate-receptor-targeted therapeutic (vintafolide) and companion SPECT-based imaging agent (99mTc-etarfolatide)

Annals of oncology, 2014-04, Vol.25 (4), p.852-858

2014

Volltextzugriff (PDF)

Phase I study of KN035, a novel fusion Anti-PD-L1 antibody administered subcutaneously in patients with advanced solid tumors in the USA

Annals of oncology, 2018-10, Vol.29, p.viii405-viii405

2018

Volltextzugriff (PDF)

363 An ongoing Phase 1 dose-escalation study of the folic acid-tubulysin small-molecule drug conjugate (SMDC) folate-tubulysin EC1456

European journal of cancer (1990), 2015-09, Vol.51, p.S75-S75

2015

Volltextzugriff (PDF)

Avelumab or talazoparib in combination with binimetinib in metastatic pancreatic ductal adenocarcinoma: dose-finding results from phase Ib of the JAVELIN PARP MEKi trial

ESMO open, 2023-08, Vol.8 (4), p.101584-101584, Article 101584

2023

Volltextzugriff (PDF)

Advancing Nursing Practice: The Emergence of the Role of Advanced Practice Nurse in Saudi Arabia

Annals of Saudi medicine, 2017-01, Vol.37 (1), p.72-78

2017

Volltextzugriff (PDF)

338 Results from a phase 1 study of ARQ 092, a novel pan AKT-inhibitor, in subjects with advanced solid tumors or recurrent malignant lymphoma

European journal of cancer (1990), 2015-09, Vol.51, p.S66-S66

2015

Volltextzugriff (PDF)

329 A first-in-human study evaluating the safety and pharmacology of MM-151, a novel oligoclonal anti-EGFR antibody combination in patients with refractory solid tumors

European journal of cancer (1990), 2014-11, Vol.50, p.107-107

2014

Volltextzugriff (PDF)

Motivators and Barriers to Accessing Sexual Health Care Services for Transgender/Genderqueer Individuals Assigned Female Sex at Birth

Transgender health, 2019-01, Vol.4 (1), p.58-67

2019

Volltextzugriff (PDF)

KAMRA inlay implantation for presbyopia compensation: A retrospective evaluation of patient satisfaction and subjective vision 12-month postoperative

Middle East African journal of ophthalmology, 2019-04, Vol.26 (2), p.65-70

2019

Volltextzugriff (PDF)

84P Applied methodology for measure selection using connected sensors to supplement commonly used quality of life clinical outcome assessments (COAs) and optimize safety review in oncology care

ESMO open, 2024-02, Vol.9, p.102367, Article 102367

2024

Volltextzugriff (PDF)

Computer Simulation of Amide Bond Formation in Aqueous Solution

The journal of physical chemistry. A, Molecules, spectroscopy, kinetics, environment, & general theory, 2001-12, Vol.105 (51), p.11574-11581

2001

Volltextzugriff (PDF)

Effect of cucurbitacins on bilirubin–albumin binding in human plasma

Life sciences (1973), 2007-01, Vol.80 (6), p.579-585

2007

Volltextzugriff (PDF)

Phase I study of single-agent CC-292, a highly selective Bruton's tyrosine kinase inhibitor, in relapsed/refractory chronic lymphocytic leukemia

Haematologica (Roma), 2016-07, Vol.101 (7), p.e295-e298

2016

Volltextzugriff (PDF)

An improved semiempirical method for hydrated systems

Theoretical chemistry accounts, 2004-09, Vol.112 (4)

2004

Volltextzugriff (PDF)

A phase 1 study of CPI-1205, a small molecule inhibitor of EZH2, preliminary safety in patients with B-cell lymphomas

Annals of oncology, 2018-03, Vol.29, p.iii7-iii7

2018

Volltextzugriff (PDF)

612P - SPICE, a phase I study of enadenotucirev in combination with nivolumab in tumours of epithelial origin: Analysis of the metastatic colorectal cancer patients in the dose escalation phase

Annals of oncology, 2019-10, Vol.30, p.v231-v231

2019

Volltextzugriff (PDF)

SPICE, a phase I study of enadenotucirev in combination with nivolumab in tumours of epithelial origin: Analysis of the metastatic colorectal cancer patients in the dose escalation phase

Annals of oncology, 2019-10, Vol.30, p.v231

2019

Volltextzugriff (PDF)

A Model for Double Asymmetric Induction in the Stereocontrolled Reduction of Glycosyl α-Ketoesters with Oxazaborolidines

Journal of the American Chemical Society, 2004-06, Vol.126 (22), p.6996-7008

2004

Volltextzugriff (PDF)

P2.13-10 Ph I/II Study of Oral Selective AXL Inhibitor Bemcentinib (BGB324) in Combination with Erlotinib in pts with EGFRm NSCLC

Journal of thoracic oncology, 2018-10, Vol.13 (10), p.S801-S802

2018

Volltextzugriff (PDF)

Abstract OT2-01-10: A phase 1 study of RAD1901, a novel, orally available, selective estrogen receptor degrader, for the treatment of ER positive advanced breast cancer

Cancer research (Chicago, Ill.), 2016-02, Vol.76 (4_Supplement), p.OT2-01-10-OT2-01-10

2016

Volltextzugriff (PDF)

A phase I open label dose escalation trial evaluating VT1021 in patients with advanced solid tumours

Annals of oncology, 2019-10, Vol.30, p.v175

2019

Volltextzugriff (PDF)

465PA phase I open label dose escalation trial evaluating VT1021 in patients with advanced solid tumours

Annals of oncology, 2019-10, Vol.30 (Supplement_5)

2019

Volltextzugriff (PDF)

465P - A phase I open label dose escalation trial evaluating VT1021 in patients with advanced solid tumours

Annals of oncology, 2019-10, Vol.30, p.v175-v175

2019

Volltextzugriff (PDF)

612PSPICE, a phase I study of enadenotucirev in combination with nivolumab in tumours of epithelial origin: Analysis of the metastatic colorectal cancer patients in the dose escalation phase

Annals of oncology, 2019-10, Vol.30 (Supplement_5)

2019

Volltextzugriff (PDF)

Abstract P2-08-06: A phase 1 study of RAD1901, a novel, oral selective estrogen receptor degrader, for the treatment of ER-positive advanced breast cancer

Cancer research (Chicago, Ill.), 2017-02, Vol.77 (4_Supplement), p.P2-P2-08-06

2017

Volltextzugriff (PDF)

1 – 25 von 384

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(341)
Mit Volltextzugriff
(309)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Phase II study of treatment of advanced ovarian cancer with folate-receptor-targeted therapeutic (vintafolide) and companion SPECT-based imaging agent (99mTc-etarfolatide)

Phase I study of KN035, a novel fusion Anti-PD-L1 antibody administered subcutaneously in patients with advanced solid tumors in the USA

363 An ongoing Phase 1 dose-escalation study of the folic acid-tubulysin small-molecule drug conjugate (SMDC) folate-tubulysin EC1456

Avelumab or talazoparib in combination with binimetinib in metastatic pancreatic ductal adenocarcinoma: dose-finding results from phase Ib of the JAVELIN PARP MEKi trial

Advancing Nursing Practice: The Emergence of the Role of Advanced Practice Nurse in Saudi Arabia

338 Results from a phase 1 study of ARQ 092, a novel pan AKT-inhibitor, in subjects with advanced solid tumors or recurrent malignant lymphoma

329 A first-in-human study evaluating the safety and pharmacology of MM-151, a novel oligoclonal anti-EGFR antibody combination in patients with refractory solid tumors

Motivators and Barriers to Accessing Sexual Health Care Services for Transgender/Genderqueer Individuals Assigned Female Sex at Birth

KAMRA inlay implantation for presbyopia compensation: A retrospective evaluation of patient satisfaction and subjective vision 12-month postoperative

84P Applied methodology for measure selection using connected sensors to supplement commonly used quality of life clinical outcome assessments (COAs) and optimize safety review in oncology care

Computer Simulation of Amide Bond Formation in Aqueous Solution

Effect of cucurbitacins on bilirubin–albumin binding in human plasma

Phase I study of single-agent CC-292, a highly selective Bruton's tyrosine kinase inhibitor, in relapsed/refractory chronic lymphocytic leukemia

An improved semiempirical method for hydrated systems

A phase 1 study of CPI-1205, a small molecule inhibitor of EZH2, preliminary safety in patients with B-cell lymphomas

612P - SPICE, a phase I study of enadenotucirev in combination with nivolumab in tumours of epithelial origin: Analysis of the metastatic colorectal cancer patients in the dose escalation phase

SPICE, a phase I study of enadenotucirev in combination with nivolumab in tumours of epithelial origin: Analysis of the metastatic colorectal cancer patients in the dose escalation phase

A Model for Double Asymmetric Induction in the Stereocontrolled Reduction of Glycosyl α-Ketoesters with Oxazaborolidines

P2.13-10 Ph I/II Study of Oral Selective AXL Inhibitor Bemcentinib (BGB324) in Combination with Erlotinib in pts with EGFRm NSCLC

Abstract OT2-01-10: A phase 1 study of RAD1901, a novel, orally available, selective estrogen receptor degrader, for the treatment of ER positive advanced breast cancer

A phase I open label dose escalation trial evaluating VT1021 in patients with advanced solid tumours

465PA phase I open label dose escalation trial evaluating VT1021 in patients with advanced solid tumours

465P - A phase I open label dose escalation trial evaluating VT1021 in patients with advanced solid tumours

612PSPICE, a phase I study of enadenotucirev in combination with nivolumab in tumours of epithelial origin: Analysis of the metastatic colorectal cancer patients in the dose escalation phase

Abstract P2-08-06: A phase 1 study of RAD1901, a novel, oral selective estrogen receptor degrader, for the treatment of ER-positive advanced breast cancer

Suchergebnisse filtern